Vista previa | Fecha de publicación | Título | Autor(es) | Acceso |
![Tesis Muriel Serrano, Javier.pdf.jpg](/retrieve/6ba1dab0-1810-49f2-92e6-5007dd9bd6dd/Tesis%20Muriel%20Serrano%2c%20Javier.pdf.jpg) | 26-jul-2019 | Tratamiento del trastorno por consumo de opioides de prescripción, en pacientes con dolor crónico no oncológico: efectividad, seguridad y marcadores farmacogenéticos | Muriel, Javier | ![](/image/openAccess.png) |
![Clinical prediction of opioid use disorder in chronic pain patients. A cohort-retrospective study with a pharmacogenetic approach.pdf.jpg](/retrieve/a558ddfe-37b5-4dd4-8872-0167dd3ecf23/Clinical%20prediction%20of%20opioid%20use%20disorder%20in%20chronic%20pain%20patients.%20A%20cohort-retrospective%20study%20with%20a%20pharmacogenetic%20approach.pdf.jpg) | 12-abr-2024 | Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach | Escorial, Mónica; Muriel, Javier; Agulló, Laura; Zandonai, Thomas; Margarit, César; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Oxycodonenaloxone - naloxone versus tapentadol in real-world chronic non-cancer pain management.an observational and pharmacogenetic study.pdf.jpg](/retrieve/49e3f51c-59c2-43d1-9d15-6d348e3d5cf2/Oxycodonenaloxone%20-%20naloxone%20versus%20tapentadol%20in%20real-world%20chronic%20non-cancer%20pain%20management.an%20observational%20and%20pharmacogenetic%20study.pdf.jpg) | jun-2022 | Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study | Barrachina, Jordi; Margarit, César; Muriel, Javier; López‑Gil, Santiago; López Gil, Vicente; Vara-González, Amaya; Planelles, Beatriz; Inda, María del Mar; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![Long-term deprescription in chronic pain and opioid use disorder patients. Pharmacogenetic and sex differences.pdf.jpg](/retrieve/442d251d-8781-4a09-b495-e3bbda10e4df/Long-term%20deprescription%20in%20chronic%20pain%20and%20opioid%20use%20disorder%20patients.%20Pharmacogenetic%20and%20sex%20differences.pdf.jpg) | 18-nov-2022 | Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences | Muriel, Javier; Escorial, Mónica; Margarit, César; Barrachina, Jordi; Carvajal, Cristian; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |
![CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder. A Naturalistic Study with Extreme Phenotype Analysis.pdf.jpg](/retrieve/78002e9d-ad29-4c4a-8e05-a953980ab181/CYP2D6%20Genotype%20and%20Pharmacovigilance%20Impact%20on%20Autism%20Spectrum%20Disorder.%20A%20Naturalistic%20Study%20with%20Extreme%20Phenotype%20Analysis.pdf.jpg) | 3-jul-2023 | CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis | Ballester, Purificación; Espadas, Cristina; Almenara, Susana; Barrachina, Jordi; Muriel, Javier; Ramos, Enrique; Toral, Natalia; Belda, César; Peiró, Ana | ![](/image/openAccess.png) |
![CYP2D6 phenotypes and opioid metabolism. the path to personalised analgesia.pdf.jpg](/retrieve/8a3fbbc5-ffc9-46b8-b233-5a18818cb254/CYP2D6%20phenotypes%20and%20opioid%20metabolism.%20the%20path%20to%20personalised%20analgesia.pdf.jpg) | abr-2022 | CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia | Ballester, Purificación; Muriel, Javier; Peiró, Ana | ![](/image/closedAccess.png) |
![The challenge of detecting adverse events in adults with autism.pdf.jpg](/retrieve/d98d8190-390a-400b-b2d5-c2701c7e0b73/The%20challenge%20of%20detecting%20adverse%20events%20in%20adults%20with%20autism.pdf.jpg) | may-2021 | The challenge of detecting adverse events in adults with autism spectrum disorder who have intellectual disability | Ballester, Purificación; Espadas, Cristina; Londoño, Ana C.; Almenara, Susana; Aguilar, Víctor; Belda, César; Pérez, Enrique; Muriel, Javier; Peiró, Ana | ![](/image/openAccess.png) |
![Gender based differences, pharmacogenetics and adverse events.pdf.jpg](/retrieve/f00b8b99-2361-4ae9-8c35-e47b46087ab1/Gender%20based%20differences%2c%20pharmacogenetics%20and%20adverse%20events.pdf.jpg) | abr-2020 | Gender based differences, pharmacogenetics and adverse events in chronic pain management | Planelles, Beatriz; Margarit, César; Inda, María del Mar; Ballester, Purificación; Muriel, Javier; Barrachina, Jordi; Ajo Ferrer, Raquel; Esteban, maría Dolores; Peiró, Ana | ![](/image/closedAccess.png) |
![Evaluation of agomelatine for the.pdf.jpg](/retrieve/b150447c-889c-4918-90ff-5a017774d4f3/Evaluation%20of%20agomelatine%20for%20the.pdf.jpg) | nov-2019 | Evaluation of agomelatine for the treatment of sleep problems in adults with autism spectrum disorder and co-morbid intellectual disability | Ballester, Purificación; Martínez, María José; Inda, María del Mar; Javaloyes, María Auxiliadora; Richdale, Amanda; Muriel, Javier; Belda, César; Toral, Natalia; Morales, Domingo; Fernández, Eduardo; Peiró, Ana | ![](/image/closedAccess.png) |
![Genetic Contribution in Low Back Pain A.pdf.jpg](/retrieve/12826335-b1c3-4c95-8b65-6867cf467acf/Genetic%20Contribution%20in%20Low%20Back%20Pain%20A.pdf.jpg) | nov-2019 | Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study | Margarit, César; Roca, Reyes; Inda, María del Mar; Muriel, Javier; Ballester, Purificación; Moreu, Rocio; CONTE, LUCIA; Nuñez, Ángela; Morales, Domingo; Peiró, Ana | ![](/image/openAccess.png) |